Document is current
Any future updates will be listed below
-
Authors
van Wijk, Meike W. M. https://orcid.org/0000-0002-4626-6694
Janssen, Marcel J. R.
Arntz, Mark J.
Geurts, Bram H. J.
Michon, Laura A.
Tjwa, Eric T. T. L.
Roosen, Joey
Nijsen, J. Frank W.
-
Funding
Funding for this research was provided by:
Quirem Medical B.V. - a Terumo Company (Quirem Medical B.V. - a Terumo Company)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 25 June 2025
First Online: 8 July 2025
Declarations
:
: Both patients were included in the EMERITUS2 study (NCT05609448) which was approved by the medical ethical committee (METC Oost-Nederland).
: Both patients gave written informed consent for inclusion in the clinical trial and use of their medical data for further research purposes, including publication of these results.
: JFWN is co-founder and scientific advisor of Quirem Medical which has been acquired by Terumo Europe NV in July 2020. The activities of JFWN within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. JFWN is entitled to certain milestone payments from Terumo which are related to Quirem’s financial, operational and regulatory performance in the future.
